SEP-SEQ Trial - Determining the Etiology of Sepsis Using an Infectious Disease Diagnostic Sequencing Assay

Completed

Conditions studied: Sepsis

In brief

The purpose of this study is to evaluate the performance of the Karius Infectious Diseases Plasma Sequencing Assay in patients who present to the emergency room with sepsis.

Key facts

Study ID

NCT02730468

Run by

Karius, Inc.

People needed

350

Starts

2016-04-01

Expected to finish

2017-10-01

Last updated by the study team

2017-10-27

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• 18 years or older
• Meet 2 of 4 sepsis criteria
• Temperature > 38C or < 36C
• Heart rate > 90 bpm
• Respiratory rate >20 or PaCO2 <32mmHg
• WBC >12000/µL or < 4000/µL or > 10% bands

You may not qualify if…

• Inability to understand instructions and comply with study-related procedures
• Any condition that in the opinion of the treating physician will prevent the subject from completing the study.

Where it is running

• Stanford University Hospital — Stanford, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.